Brief: Biora Therapeutics Inc - On December 6, Co Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq - Filing
09/12/2022 22:16
Dec 9 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS INC - ON DECEMBER 6, CO RECEIVED NOTICE
OF
DELISTING OR FAILURE TO SATISFY A CONTINUED LISTING RULE OR
STANDARD FROM NASDAQ
Further company coverage: BIOR.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules